Joxson & Joxson

Joxson & Joxson operates massive bio-factories on asteroid belts to synthesize patent-compound synthetics for mass-market pharmaceuticals, including next-generation neuro-regeners and weight-control GLP-1 analogs. While publicly focused on consumer wellness and hygiene for the off-world colonies, the conglomerate quietly manages the most extensive portfolio of litigation and biotech R&D in the sector.

Founded in the chaotic post-colonization era by twins who repurposed a failing hydrogen-refining plant into a sterile biolab, the company famously survived a planetary plague by synthesizing a masked-respiration compound that became their first blockbuster, though the process involved a controversial re-classification of experimental sedatives under urgency protocols.